The question is no longer simply how to attract healthcare professionals to an event. The bigger challenge is how to create meaningful engagement.
In recognition of Stand Up To Cancer Day, a look at next-generation treatments that are on the verge of making it into clinical practice.
The UK must sustain investment in malaria R&D as it faces a “perfect storm” of challenges, including mosquito resistance to existing tools.
Whether a drug can secure reimbursement is pharma's billion-dollar question, and the companies that succeed will be those that answer it sooner.
The future of drug development is not scientists versus algorithms. It is scientists and algorithms working together.
Editor's Picks
